Injection-Related Risks When using injectable BPC-157, risks include: Infection at the injection site Tissue irritation Incorrect dosage due to inconsistent product purity in research-grade peptides Purity and Sourcing Concerns Not all peptides are created equal
Moreover, female genital-tract HIV load correlates inversely with vaginal lactobacilli bacterial counts (10)
Overall, it is best to consult your healthcare provider before making any significant changes to your routine, be it adding berberine to your regimen or something else
it should only be accessed through legitimate clinical trials
A rating scale for fibromyalgia and chronic fatigue syndrome (the FibroFatigue scale)
References Yammine L, Grigson PS, Schmitz JM, Evans BB, Hendershot CS